PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 78 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,241 | -44.7% | 1,434 | -44.9% | 0.00% | – |
| Q2 2023 | $13,088 | +118881.8% | 2,602 | +47.2% | 0.00% | – |
| Q1 2023 | $11 | -63.3% | 1,768 | -22.3% | 0.00% | -100.0% |
| Q4 2022 | $30 | -99.9% | 2,274 | -83.7% | 0.00% | 0.0% |
| Q3 2022 | $42,000 | +4100.0% | 13,991 | +11183.1% | 0.00% | – |
| Q1 2022 | $1,000 | -98.8% | 124 | -98.8% | 0.00% | -100.0% |
| Q4 2021 | $80,000 | -70.3% | 9,921 | -44.9% | 0.00% | -85.7% |
| Q3 2021 | $269,000 | +572.5% | 17,997 | +464.0% | 0.01% | +600.0% |
| Q2 2021 | $40,000 | -62.6% | 3,191 | -86.4% | 0.00% | -50.0% |
| Q1 2021 | $107,000 | +1683.3% | 23,447 | +763.0% | 0.00% | – |
| Q3 2020 | $6,000 | +100.0% | 2,717 | +634.3% | 0.00% | – |
| Q1 2019 | $3,000 | – | 370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |